India emerging as favourable destination to conduct global clinical trials: Report

The joint report by the USA India Chamber of Commerce & PwC India titled, “Clinical Trial opportunities in India” which will be released at the virtual edition of the 17th annual BioPharma & Healthcare Summit 2023 to be held on Wednesday in Boston also indicates that through several key drivers, India is emerging as a favourable destination to conduct clinical trials.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Rt7Cyne
via IFTTT